Table 1. Human Plasma-derived Hyperimmune Product Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Human Plasma-derived Hyperimmune Product Market Restraints

Table 3. Human Plasma-derived Hyperimmune Product Market Trends

Table 4. Human Plasma-derived Hyperimmune Product Industry Policy

Table 5. Global Human Plasma-derived Hyperimmune Product Revenue by Company, 2019-2024, US$ million

Table 6. Global Human Plasma-derived Hyperimmune Product Revenue Market Share by Company, 2019-2024

Table 7. Global Human Plasma-derived Hyperimmune Product Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share by Company, 2019-2024

Table 9. Global Human Plasma-derived Hyperimmune Product Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Human Plasma-derived Hyperimmune Product Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Human Plasma-derived Hyperimmune Product Mergers & Acquisitions, Expansion Plans

Table 12. Global Human Plasma-derived Hyperimmune Product Manufacturers Product Type

Table 13. China Human Plasma-derived Hyperimmune Product Revenue by Company, 2019-2024, US$ million

Table 14. China Human Plasma-derived Hyperimmune Product Revenue Market Share by Company, 2019-2024

Table 15. China Human Plasma-derived Hyperimmune Product Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Human Plasma-derived Hyperimmune Product Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Human Plasma-derived Hyperimmune Product Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Human Plasma-derived Hyperimmune Product Import & Export Trends

Table 19. Main Sources of China Human Plasma-derived Hyperimmune Product Import

Table 20. Export Destination of China Human Plasma-derived Hyperimmune Product

Table 21. Global Headquarters and Manufacturing Base of Human Plasma-derived Hyperimmune Product Manufacturers

Table 22. Global Major Manufacturers, Human Plasma-derived Hyperimmune Product Capacity Expansion and Future Plans

Table 23. Global Human Plasma-derived Hyperimmune Product Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Human Plasma-derived Hyperimmune Product Production by Region, 2019-2024, (K Units)

Table 25. Global Human Plasma-derived Hyperimmune Product Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Human Plasma-derived Hyperimmune Product Upstream (Raw Materials)

Table 27. Global Human Plasma-derived Hyperimmune Product Typical Customers

Table 28. Human Plasma-derived Hyperimmune Product Typical Distributors

Table 29. By Type, Global Human Plasma-derived Hyperimmune Product Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Human Plasma-derived Hyperimmune Product Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Human Plasma-derived Hyperimmune Product Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Human Plasma-derived Hyperimmune Product Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Human Plasma-derived Hyperimmune Product Revenue Market Share, 2019-2030

Table 37. By Country, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2019-2030

Table 39. CSL Behring Company Information, Head Office, Market Area and Industry Position

Table 40. CSL Behring Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 41. CSL Behring Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. CSL Behring Company Profile and Main Business

Table 43. CSL Behring Recent Developments

Table 44. Grifols Company Information, Head Office, Market Area and Industry Position

Table 45. Grifols Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 46. Grifols Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Grifols Company Profile and Main Business

Table 48. Grifols Recent Developments

Table 49. Biotest Company Information, Head Office, Market Area and Industry Position

Table 50. Biotest Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 51. Biotest Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Biotest Company Profile and Main Business

Table 53. Biotest Recent Developments

Table 54. Kedrion Company Information, Head Office, Market Area and Industry Position

Table 55. Kedrion Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 56. Kedrion Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Kedrion Company Profile and Main Business

Table 58. Kedrion Recent Developments

Table 59. CBPO Company Information, Head Office, Market Area and Industry Position

Table 60. CBPO Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 61. CBPO Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. CBPO Company Profile and Main Business

Table 63. CBPO Recent Developments

Table 64. Emergent (Cangene) Company Information, Head Office, Market Area and Industry Position

Table 65. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 66. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Emergent (Cangene) Company Profile and Main Business

Table 68. Emergent (Cangene) Recent Developments

Table 69. Kamada Company Information, Head Office, Market Area and Industry Position

Table 70. Kamada Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 71. Kamada Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Kamada Company Profile and Main Business

Table 73. Kamada Recent Developments

Table 74. CNBG Company Information, Head Office, Market Area and Industry Position

Table 75. CNBG Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 76. CNBG Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. CNBG Company Profile and Main Business

Table 78. CNBG Recent Developments

Table 79. Hualan Bio Company Information, Head Office, Market Area and Industry Position

Table 80. Hualan Bio Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 81. Hualan Bio Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Hualan Bio Company Profile and Main Business

Table 83. Hualan Bio Recent Developments

Table 84. Shanghai RAAS Company Information, Head Office, Market Area and Industry Position

Table 85. Shanghai RAAS Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 86. Shanghai RAAS Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Shanghai RAAS Company Profile and Main Business

Table 88. Shanghai RAAS Recent Developments

Table 89. Sichuan Yuanda Shuyang Company Information, Head Office, Market Area and Industry Position

Table 90. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 91. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Sichuan Yuanda Shuyang Company Profile and Main Business

Table 93. Sichuan Yuanda Shuyang Recent Developments

Table 94. ADMA Biologics Company Information, Head Office, Market Area and Industry Position

Table 95. ADMA Biologics Human Plasma-derived Hyperimmune Product Models, Specifications and Application

Table 96. ADMA Biologics Human Plasma-derived Hyperimmune Product Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. ADMA Biologics Company Profile and Main Business

Table 98. ADMA Biologics Recent Developments

List of Figure

Figure 1. Human Plasma-derived Hyperimmune Product Picture

Figure 2. By Revenue, Global Human Plasma-derived Hyperimmune Product Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Human Plasma-derived Hyperimmune Product Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Human Plasma-derived Hyperimmune Product Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Human Plasma-derived Hyperimmune Product Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Human Plasma-derived Hyperimmune Product Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Human Plasma-derived Hyperimmune Product Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Human Plasma-derived Hyperimmune Product Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Human Plasma-derived Hyperimmune Product Share of Global Market, 2019-2030

Figure 10. Global Human Plasma-derived Hyperimmune Product Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Human Plasma-derived Hyperimmune Product Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Human Plasma-derived Hyperimmune Product Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Human Plasma-derived Hyperimmune Product Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Human Plasma-derived Hyperimmune Product Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Human Plasma-derived Hyperimmune Product Domestic VS Export, 2022

Figure 16. Global Human Plasma-derived Hyperimmune Product Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Human Plasma-derived Hyperimmune Product Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Human Plasma-derived Hyperimmune Product Production Market Share & Forecast by Region, 2019-2030

Figure 19. Human Plasma-derived Hyperimmune Product Industry Chain

Figure 20. Human Plasma-derived Hyperimmune Product Procurement Model

Figure 21. Human Plasma-derived Hyperimmune Product Sales Model

Figure 22. Human Plasma-derived Hyperimmune Product Sales Channels, Direct Sales and Distribution

Figure 23. Hepatitis B Immunoglobulins

Figure 24. Rabies Immunoglobulins

Figure 25. Tetanus Immunoglobulins

Figure 26. Rho(D) Immunoglobulins

Figure 27. Other

Figure 28. By Type, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030, US$ Million

Figure 29. By Type, Global Human Plasma-derived Hyperimmune Product Revenue Market Share, 2019-2030

Figure 30. By Type, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 31. By Type, Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2019-2030

Figure 32. By Type, Global Human Plasma-derived Hyperimmune Product Price, 2019-2030, (US$/Unit)

Figure 33. Government Institution

Figure 34. Private Sector

Figure 35. Others

Figure 36. By Application, Global Human Plasma-derived Hyperimmune Product Revenue, 2019-2030, US$ Million

Figure 37. By Application, Global Human Plasma-derived Hyperimmune Product Revenue Market Share, 2019-2030

Figure 38. By Application, Global Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 39. By Application, Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2019-2030

Figure 40. By Application, Global Human Plasma-derived Hyperimmune Product Price, 2019-2030, (US$/Unit)

Figure 41. By Region, Global Human Plasma-derived Hyperimmune Product Revenue Market Share, 2019-2030

Figure 42. By Region, Global Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2019-2030

Figure 43. North America Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, North America Human Plasma-derived Hyperimmune Product Revenue Market Share, 2022

Figure 45. Europe Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country, Europe Human Plasma-derived Hyperimmune Product Revenue Market Share, 2022

Figure 47. Asia Pacific Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country/Region, Asia Pacific Human Plasma-derived Hyperimmune Product Revenue Market Share, 2022

Figure 49. South America Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. By Country, South America Human Plasma-derived Hyperimmune Product Revenue Market Share, 2022

Figure 51. Middle East & Africa Human Plasma-derived Hyperimmune Product Revenue & Forecasts, 2019-2030, US$ Million

Figure 52. U.S. Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 53. By Company, U.S. Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 54. By Type, U.S. Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, U.S. Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 56. Europe Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 57. By Company, Europe Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 58. By Type, Europe Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, Europe Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 60. China Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 61. By Company, China Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 62. By Type, China Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, China Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 64. Japan Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 65. By Company, Japan Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 66. By Type, Japan Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, Japan Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 68. South Korea Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 69. By Company, South Korea Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 70. By Type, South Korea Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, South Korea Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 72. Southeast Asia Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 73. By Company, Southeast Asia Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 74. By Type, Southeast Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, Southeast Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 76. India Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 77. By Company, India Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 78. By Type, India Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, India Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 80. Middle East & Asia Human Plasma-derived Hyperimmune Product Sales Volume, 2019-2030, (K Units)

Figure 81. By Company, Middle East & Asia Human Plasma-derived Hyperimmune Product Market Share, 2022

Figure 82. By Type, Middle East & Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 83. By Application, Middle East & Asia Human Plasma-derived Hyperimmune Product Sales Volume Market Share, 2022 VS 2029

Figure 84. Research Methodology

Figure 85. Breakdown of Primary Interviews

Figure 86. Bottom-up Approaches

Figure 87. Top-down Approaches